Aqsens Health’s 2023 wrap-up
It’s time to wrap-up Aqsens Health’s 2023, a year of major scientific steps and large clinical trial kick-offs!
AQ Lab beta testing completed and the platform is ready for commercial deployment
After a year of development and a few months of final beta testing, AQ Lab is ready to be deployed as a research and development platform for E-TRF and biosensor-based projects.
Aqsens Health starting pre-clinical trials for urinary tract cancer detection in China
Aqsens Health and its Chinese partner OG Pharmaceuticals have received funding for a joint prostate and bladder cancer pre-clinical and clinical research project in Jiangsu Province in China.
Professor Tambet Teesalu joins Aqsens Health’s scientific advisors as a Senior Advisor in biosensor technology
Aqsens Health is happy to share that our scientific advisory team will be strengthened with Professor Tambet Teesalu’s phage and biosensor expertise.
“Finns don’t joke with time” – Elizabeth is back and getting settled into her life in Finland
After two years of working together with Aqsens Health through our malaria research project with the Noguchi Memorial Institute for Medical Research in Ghana, Elizabeth Cudjoe returned to Finland to work as a Senior Application Scientist at Aqsens Health.
Paving the way to the world’s largest single market – Interview with Aqsens Health’s Senior Project Manager Zhao Zhao
Zhao took the time to answer a few questions about her role at Aqsens, what she looks forward to when managing impactful projects in China , and what she thinks are the most important success factors when collaborating with Chinese partners.
Aqsens Health, Tyks and Auria Biobank join forces for a research study to detect and classify bladder cancer with phage-biosensors
Aqsens Health, Turku University Hospital (Tyks) and Auria Biobank join forces for a bladder cancer research study. This local research collaboration aims to see whether Aqsens Health’s biosensors can be used in the detection and classification of bladder cancer, focusing especially on non-invasive monitoring of bladder cancer tumor development, relapse, and recurrence.
BIOSALIVA – Aqsens Health and Shanghai Jiao Tong University begin research on early detection of lung cancer and tuberculosis
Aqsens Health and research teams from the Shanghai Jiao Tong University and Shanghai Public Health Clinical Center have received research funding from China’s Ministry of Science and Technology and Business Finland to start a research collaboration focusing on the detection of lung cancer and tuberculosis from saliva samples.
Aqsens Health and Tartu University teaming up to research the capabilities of different phages as biosensors in diagnostics
Aqsens Health is pleased to announce its collaboration with Professor Tambet Teesalu's esteemed research group at the Laboratory of Precision and Nanomedicine, University of Tartu in Estonia. Together, they will delve into extensive research to explore the capabilities of different phages as biosensors.
Bladder cancer FAQ – Bladder cancer awareness month 2023
What is bladder cancer and how is it currently diagnosed? How common is it? What are the usual symptoms? Every May the World Bladder Cancer Patient Coalition celebrates bladder cancer awareness month.
How AI is shaping the Medtech industry – Interview with Professor Wei Dongqing from Shanghai Jiao Tong University
We at Aqsens Health had the opportunity to interview Professor Wei Dongqing to discuss how AI is shaping the future of the healthcare industry ahead of Aqsens and Shanghai Jiao Tong University's upcoming research collaboration.
World Malaria Day 2023 – Ghana malaria project progressing as planned
According to the newest World Malaria report (2021), the number of malaria cases worldwide has increased during the past few years. To take part in this year’s World Malaria Day, we wanted to share an update about our malaria screening test research collaboration in Ghana.
Aqsens Health’s board of directors strengthened with medtech industry expertise – An interview with Tuomo Pätsi
Aqsens Health is happy to announce that Mr. Tuomo Pätsi has been elected to Aqsens Health’s board of directors at Aqsens Health’s annual general meeting. Mr. Pätsi has over 30 years of experience in the medical industry, and he has led several biotech companies through successful market-entry and commercialization…
Time to put an end to TB – World Tuberculosis Day
Tuberculosis is a very complex health care problem that affects over 10 million people worldwide every year. It is treatable and curable, but still dangerous, especially to those with weakened immune systems…
Next practises and post-pandemic learnings for international research collaboration
Even a small company can greatly benefit from international collaborations, especially in the research and development phase. But why specifically should a health technology or biotechnology start-up look into the possibility of international collaboration?
If you set your mind to it, you can make it happen – Women and Girls in Science and Technology 2023
Every year the 11th of February is dedicated to the UN Day for Women and Girls in Science and Technology that recognizes the role of women in science, and encourages girls to pursue studies and careers in traditionally male-dominated fields. To celebrate the date, we had the opportunity to ask our friends and colleagues Elizabeth and Jasmine who work at the Noguchi Memorial Institute for Medical Research in Ghana about her studies and work in medical research.
Joining forces to create new innovative solutions – World Cancer Day 2023
The 2023 World Cancer Day continues the campaign to “Close the care gap”. This year the focus is on uniting our voices and joining forces to work together to achieve our goals and celebrate the big and small accomplishments in cancer care and research.
Tapping into the full potential of E-TRF and biosensors
Aqsens Health’s E-TRF method and its biochemical and chemical sensors are designed and developed to build a comprehensive view of the diseases at a low-cost, making large-scale screening a concrete possibility…